Imported Lassa fever in Germany: Surveillance and management of contact persons

Clinical Infectious Diseases

Volumn 36, Issue 10, 2003, Pages 1254-1258

  Haas, Walter H ^a   Breuer, Thomas ^a,e   Pfaff, Günter ^b   Schmitz, Herbert ^c   Köhler, Päivi ^d   Asper, Marcel ^c   Emmerich, Petra ^c   Drosten, Christian ^c   Gölnitz, Uta ^c   Fleischer, Klaus ^d   Günther, Stephan ^c  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Landesgesundheitsamt Baden W   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d Missionsarztliche Klinik   (Germany)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RIBAVIRIN;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; CASE REPORT; CONTACT EXAMINATION; DIARRHEA; DISEASE COURSE; FEMALE; GERMANY; HIGH RISK POPULATION; HUMAN; JAUNDICE; LASSA FEVER; LASSA VIRUS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MYALGIA; PANCREATITIS; POPULATION EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; RASH; SERODIAGNOSIS; SUPERINFECTION; TACHYCARDIA; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CHEMOPREVENTION; GERMANY; HUMANS; IMMUNOGLOBULIN G; LASSA FEVER; LASSA VIRUS; RIBAVIRIN; RISK MANAGEMENT;

EID: 0037846089     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374853     Document Type: Article

References (19)

1. Monath TP, Mertens PE, Patton R, et al. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 1973; 22:773-9.
2. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995; 311:857-9.
3. Johnson KM, Monath TP. Imported Lassa fever - reexamining the algorithms. N Engl J Med 1990; 323:1139-41.
4. Zweighaft RM, Fraser DW, Hattwick MA, et al. Lassa fever: response to an imported case. N Engl J Med 1977;297:803-7.
5. Holmes GP, McCormick JB, Trock SC, et al. Lassa fever in the United States: investigation of a case and new guidelines for management. N Engl J Med 1990; 323:1120-3.
6. Cooper CB, Gransden WR, Webster M, et al. A case of Lassa fever: experience at St T. homas's Hospital. Br Med J (Clin Res Ed) 1982; 285:1003-5.
7. McCormick JB, King IJ, Webb PA, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med 1986; 314:20-6.
8. Günther S, Emmerich P, Laue T, et al. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emerg Infect Dis 2000; 6:466-76.
9. Fleischer K, Kohler B, Kirchner A, Schmid J. Lassa fever [in German]. Med Klin 2000;95:340-5.
10. Schmitz H, Köhler B, Laue T, et al. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect 2002;4:43-50.
11. Jahrling PB, Frame JD, Rhoderick JB, Monson MH. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg 1985; 79:380-4.
12. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 1987; 155:456-64.
13. Peters CJ, Jahrling PB, Liu CT, Kenyon RH, McKee KT, Barrera Oro JG. Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol 1987; 134:5-68.
14. Stephenson EH, Larson EW, Dominik JW. Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol 1984; 14:295-303.
15. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR Morb Mortal Wkly Rep 1995; 44:475-9.
16. Drosten C, Gottig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002; 40:2323-30.
17. Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL. Lassa virus infection of rhesus monkeysi pathogenesis and treatment with ribavirin. J Infect Dis 1980; 141:580-9.
18. Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety, and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther 1999; 4:211-9.
19. Kakuda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000; 22:685-708.